Funding M&A and new businesses through third-party allotment of stock acquisition rights
First written in FY2023. 5 of 10 entries say "Advanced", first in FY2024-Q1. Latest entry: 2026-06-25.
23 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「All exercises of these stock acquisition rights were completed as of 4 February 2026. As a result, both stated capital and capital surplus increased by ¥162,670 thousand from the end of the fiscal year ended August 2025.」
Exercises of the 13th Series of Share Acquisition Rights, for which the framework was changed in response to the previous year's shortfall against the planned scale, were completed during the interim period, covering 6,000 rights and 600,000 shares. Capital stock and the capital reserve each increased by ¥162.67 million. - FY2025ReframedAnnual report
「The Company was unable to raise funds at the originally planned scale. …The Company decided to issue the 13th Series of Share Acquisition Rights with an exercise price adjustment provision and the 1st Series of Unsecured Straight Bonds, and, in light of the fact that the necessary funds could not be secured at this time through these share acquisition rights, decided to acquire and cancel these share acquisition rights in order to eliminate a factor that would increase the total number of shares outstanding in the future.」
As fundraising through the 11th and 12th Series of Share Acquisition Rights fell short of the planned scale, the Company acquired and cancelled the outstanding rights and changed the framework to phased fundraising through the 13th Series of Share Acquisition Rights and unsecured straight bonds. - FY2025-H1AdvancedAnnual report
「Number of share acquisition rights, etc., with exercise price adjustment provisions exercised during the interim accounting period 100 Number of shares delivered in connection with exercises during the interim accounting period 10,000 Average exercise price, etc., for exercises during the interim accounting period ¥712 Funds raised through exercises during the interim accounting period ¥7.12 million」
With respect to the 11th Series of Share Acquisition Rights intended to fund growth investments in M&A and new businesses, 100 rights were exercised, 10,000 shares were delivered and ¥7.12 million was raised. - FY2024AdvancedAnnual report
「The Company has exercised its conversion right relating to the 11th Series of Share Acquisition Rights into share acquisition rights with an exercise price adjustment feature.」
With respect to the 11th and 12th Series of Share Acquisition Rights intended to fund M&A and new business initiatives, the Company actually exercised its conversion right for the 11th Series into rights with an exercise price adjustment feature. The two series cover a total of 600,000 shares. - FY2024-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 12 October 2023, the company resolved to issue, by way of a third-party allotment to Mita Securities Co., Ltd. (the “allottee”), the 11th series of stock acquisition rights (stock acquisition rights with conversion rights and an adjustable exercise price; the “11th Series Stock Acquisition Rights”) and the 12th series of stock acquisition rights (stock acquisition rights with conversion rights and an adjustable exercise price; the “12th Series Stock Acquisition Rights,” together with the 11th Series Stock Acquisition Rights, the “Stock Acquisition Rights”), as described below. Payment of the total issue price was completed on 30 October 2023. Amount of funds raised (value of the assets contributed upon exercise of the stock acquisition rights) ¥811,788,000 (estimated net proceeds: ¥780,173,000) Exercise period From 31 October 2023 to 30 October 2026 Use of funds The funds are scheduled to be allocated to growth investment in M&A and new businesses aimed at further expanding the group's business scope and strengthening its earnings power.」
Payment of the issue price for the 11th and 12th series of stock acquisition rights issued through a third-party allotment was completed, and the company moved to the stage of allocating up to ¥811,788,000 raised to growth investment in M&A and new businesses. The exercise period is from 31 October 2023 to 30 October 2026. - FY2023First statedAnnual report
「If all of these stock acquisition rights are exercised at the initial exercise price, the amount of funds raised will be ¥811,788,000 (estimated net proceeds: ¥780,173,000), which is scheduled to be allocated to growth investment in M&A and new businesses aimed at further expanding the group's business scope and strengthening its earnings power.」
The company has stated a plan to issue the 11th and 12th series of stock acquisition rights through a third-party allotment after the filing and allocate a maximum of approximately ¥812 million to growth investment in M&A and new businesses.